Anilocus provides comprehensive safety pharmacology studies evaluating cardiovascular, respiratory, and central nervous system effects of drug candidates. Our capabilities include specialized behavioral assessments, physiological monitoring, and tissue analysis to identify potential safety liabilities and support regulatory submissions for safe drug development programs.